Please login to the form below

Not currently logged in
Email:
Password:

MHRA's Dr June Raine to chair new EMA pharmacovigilance committee

Pharmacovigilance Risk Assessment Committee (PRAC) will lead implementation of reforms

MHRA EMA PRAC Dr June RaineThe EMA's new Pharmacovigilance Risk Assessment Committee (PRAC) has elected Dr June Raine as its chair for a three-year term.

She is director of vigilance and risk management of medicines at the UK's Medicines and Healthcare products Regulatory Agency (MHRA), a role she had held since 1999.

The PRAC will lead implementation of the wide-ranging pharmacovigilance reforms the EMA brought in over the summer. Its oversight powers include compelling the regulator to hold open hearings where the public can discuss medicine safety issues.

Dr Raine said: “The PRAC is set to play a pivotal role in delivering the public health benefits of the new European pharmacovigilance legislation.

“My ambition is to make sure that this unique opportunity to strengthen public health protection is fully realised for the benefit of all citizens in the European Union.

“The new legislation provides powerful tools to strengthen the protection of public health in Europe and the effective use of these tools will depend on clarity of vision, strong leadership, sound scientific judgement and excellent communication by the PRAC.”

The PRAC, which first met in July, also elected the Irish Medicines Board's vigilance assessment manager, human products monitoring department Dr Almath Spooner at its September meeting to serve for three-years as vice-chair.

Dr Raine and Dr Spooner were both members of the Agency's former Pharmacovigilance Working Party, which was wound up in July.

10th September 2012

From: Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

NICE
Evolution or revolution: the latest review of NICE methods
By Leela Barham...
PRO
Integrating patient reported outcomes into clinical trials
How capturing the patient voice is unlocking medicines’ commercial potential...
Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...

Infographics